- Tiotropium+olodaterol Respimat® with exercise training and behaviour modification significantly increased exercise capacity compared to placebo1,2
- PHYSACTO® trial data also showed improvements in shortness of breath associated with physical activity for people taking tiotropium+olodaterol Respimat® compared to placebo1
- Even in early chronic obstructive pulmonary disease (COPD) stages, decreasing activity is a strong predictor of disease worsening and increases the risk of disability and death3,4
ACTUALITES
New Data: Spiolto® Respimat® significantly improves exercise capacity in people ...- 5 Septembre 2016
Dans la même rubrique :
Pour toute information, contactez-nous au : +(235) 99267667 ; 62883277 ; 66267667 (Bureau N'Djamena)
|
Populaires
TRIBUNE & DEBATS
POINT DE VUE - 03/05/2024 - Amina Priscille Longoh
Amina Priscille Longoh : « Pourquoi je vote Mahamat Idriss Déby Itno »
|
|